Strikingly, FMR1 mRNA expression was increased with a high statistical significance in the more aggressive TNBC subtype (i.e. ER/PgR and HER2 negative) compared to the ER/PgR and/or the HER2 positive tumours (Fig 1G). Here, FMR1 is linked to neoplasm.